Press Releases
TCR2 Therapeutics Prices IPO Of 5 Mln Shares At $15.00/shr
(RTTNews) Feb 13, 2019 - TCR2 Therapeutics Inc. (TCRR) said [...]
iTeos Therapeutics Completes $75 Million Series B Financing
- Oversubscribed financing round led by new U.S. investor MPM [...]
TCR2 Therapeutics Raises $125 Million in Oversubscribed Series B Financing
Proceeds will support clinical development of lead program TC-210 and [...]
CoStim Pharmaceuticals, Inc. Acquired by Novartis
BOSTON, Feb. 17, 2014 /PRNewswire/ -- MPM Capital and Atlas Venture announced today [...]